resmetirom
FDA Believed Poised to Approve First Med for a Serious Liver Disease
2024-03-13 16:49:07
by
Dan McCue
WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week. Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often... Read More
Straight From The Well